NCT03211286View on ClinicalTrials.gov

Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

March 2, 2021

Study Completion Date

March 8, 2022

Conditions
Hip FracturesAnemia
Interventions
DRUG

Tranexamic Acid

1 g of intravenous tranexamic acid in 100 mL of saline solution

DRUG

Saline Solution

saline solution 100 mL intravenous

Trial Locations (2)

03600

Elda University Hospital, Elda

Hospital Universitario de Elda, Elda

All Listed Sponsors
collaborator

University of Alicante

OTHER

lead

Alejandro Lizaur-Utrilla, PhD, MD

OTHER

NCT03211286 - Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients | Biotech Hunter | Biotech Hunter